Job/Unit: Z13065
/KAP1
Date: 26-04-13 16:27:20
Pages: 8
J. Schottenheim, N. Fateeva, W. Thimm, J. Krahmer, F. Tuczek
ARTICLE
Synthesis of [CuILbzm1(DTBP)(NEt3)] (2bzm
)
In order to remove HCl, 1-methyl-2-(2-aminoethyl)-benzimidazole
dihydrochloride (1.00 g, 4.03 mmol) was diluted in a methanol-chloro-
form mixture (250 mL, 4:1) and a 1 m methanol sodium hydroxide
solution (12.5 mL) was added. The solution was stirred at room tem-
perature for 4 h and the solvent was removed under reduced pressure.
The residue was diluted in a minimum amount of water and toluene
(100 mL) was added. The aqueous phase was extracted three times
with toluene (25 mL) and the combined organic phases were evapo-
rated to give 430 mg (61%) of 1-methyl-2-(2-aminoethyl)-benzimid-
azole as a pink solid.
A solution of NEt3 (19.0 mg, 187 μmol) and K-DTBP (Potassium-2,4-
di-tert-butyl-phenol) (45.6 mg, 187 μmol) in dichloromethane (5 mL)
was added under Schlenk conditions to a solution of CuLbzm
(100 mg, 187 μmol) in dichloromethane (5 mL) and stirred under nitro-
gen for 15 min at room temperature. The reaction mixture was filtered
through a frit and the solution was evaporated to obtain 60 mg (40%)
of a brown powder.
1
1H NMR (400 MHz, CD2Cl2, 300 K): δ = 7.27 (d, 1 H, DTBP H-3),
7.76 (s, 1 H, imine H), 7.26–7.14 (m, 4 H, bzm H-4, H-5, H-6, H-7),
7.05 (dd, 2 H, DTBP H-5, H-6), 4.14 (s, 2 H, CH2-imine), 3.62 (s,
3 H, CH3-N), 3.28 (s, 2 H, CH2-bzm), 1.39 (s, 9 H, (-CH3)3)-DTBP),
1.28 (s, 9 H, (-CH3)3)-DTBP), 1.26 (s, 2 H, CH2-triethylamine),
1.24 (s, 2 H, CH2-triethylamine), 1.16 (s, 18 H, (-CH3)3)-Lbzm1,
CH3-triethylamine), 1.03 (s, 2 H, CH2-triethylamine).
C10H13N3 (M = 175.23 g·mol–1); C 68.62 (calcd. 68.54); H 8.92 (8.48);
N 23.98 (22.94); Cl 0.00 (0.00)%. 1H NMR (400 MHz, MeOD,
300 K): δ = 7.50–7.32 (m, 2 H, bzm H-4, bzm H-7), 7.13 (m, 2 H, bzm
H-5, bzm H-6), 3.69 (s, 3 H, CH3-N), 3.73 (s, 3 H, CH3-N), 3.01 (m,
4 H, CH2-bzm, CH2-amine). 13C NMR (100 MHz, MeOD, 300 K): δ
= 154.98 (Cq, bzm C-2), 142.95 (Cq, bzm C-3a), 136.92 (Cq, bzm
C-7a), 123.56 (CH, bzm C-6), 123.21 (CH, bzm C-5), 119.02 (CH, bzm
C-4), 110.73 (CH, bzm C-7), 40.40 (CH2, CH2-imine), 31.02 (CH2,
CH2-bzm), 30.10 (CH3, CH3-N).
Supporting Information (see footnote on the first page of this article)
Acknowledgments
The authors thank Deutsche Forschungsgemeinschaft (DFG) and CAU
Kiel for support of this research.
Synthesis of Lbzm
1
For the preparation of Lbzm1 a mixture of 1-methyl-2-(2-aminoethyl)-
benzimidazole (240 mg, 1.37 mmol), trimethylacetaldehyde (120 mg,
1.39 mmol) and a catalytic amount of p-toluenesulfonic acid mono-
hydrate in toluene (20 mL) was stirred under reflux and removal of
water using a Dean–Stark trap for 5 d. After cooling to room tempera-
ture the solution was decanted from the catalyst. The solution was
evaporated and there 309 mg (93%) of yellow-brown oil were
obtained. The ligand was used without further purification for the syn-
thesis of the CuLbzm1 complex (see below).
References
[1] M. Rolff, J. Schottenheim, H. Decker, F. Tuczek, Chem. Soc. Rev.
2011, 40, 4077.
[2] A. Sanchez-Ferrer, J. N. Rodrι´guez-López, F. Garcι´a-Cánovas, F.
Garcι´a-Carmona, Biochim. Biophys. Acta Prot. Struct. Mol. En-
zym. 1995, 1247, 1.
[3] K. E. van Holde, K. I. Miller, H. Decker, J. Biol. Chem. 2001,
276, 15563.
[4] Y. Matoba, T. Kumagai, A. Yamamoto, H. Yoshitsu, M. Sugi-
yama, J. Biol. Chem. 2006, 281, 8981.
1H NMR (400 MHz, CDCl3, 300 K): δ = 7.44 (s, 1 H, imine H), 7.28–
7.12 (m, 4 H, bzm H), 3.86 (t, 2 H, CH2-imine), 3.73 (s, 3 H, CH3-N),
3.17 (t, 2 H, CH2-bzm), 0.91 (s, 9 H, CH3). 13C NMR (100 MHz,
CDCl3, 300 K): δ = 173.80 (CH, imine C), 153.62 (Cq, bzm C-2),
142.54 (Cq, bzm C-3a), 135.52 (Cq, bzm C 7a), 121.98 (CH, bzm C-
6), 121.78 (CH, bzm C-5), 119.02 (CH, bzm C-4), 108.92 (CH, bzm
C-7), 59.71 (CH2, CH2-imine), 35.93 (Cq, C-(CH3)3), 29.95 (CH3,
CH3-N), 28.81 (CH2, CH2-bzm), 26.62 (CH3, (-CH3)3).
[5] a) M. Sendovski, M. Kanteev, V. S. Ben-Yosef, N. Adir, A. Fish-
man, J. Mol. Biol. 2011, 405, 227; b) W. T. Ismaya, H. J. Roze-
boom, A. Weijn, J. J. Mes, F. Fusetti, H. J. Wichers, B. W. Dijk-
stra, Biochemistry 2011, 50, 5477; c) Y. Li, Y. Wang, H. Jiang, J.
Deng, Proc. Natl. Acad. Sci. USA 2009, 106, 17002.
[6] H. Decker, T. Schweikardt, F. Tuczek, Angew. Chem. 2006, 118,
4658.
[7] C. Eicken, C. Gerdemann, B. Krebs in Handbook of Metallo-
proteins (Eds.: A. Messerschmidt, R. Huber, T. Poulos,
K. Wieghardt), Wiley, New York, 2001, Vol. 2, p. 1319.
[8] E. A. Lewis, W. B. Tolman, Chem. Rev. 2004, 104, 1047.
[9] L. M. Mirica, X. Ottenwaelder, T. D. P. Stack, Chem. Rev. 2004,
104, 1013.
Synthesis of [CuILbzm1(CH3CN)2] PF6 (CuLbzm1)
A
solution of tetrakis(acetonitrile)copper(I) hexafluorophosphate
[10] I. A. Koval, P. Gamez, C. Belle, K. Selmeczi, J. Reedijk, Chem.
Soc. Rev. 2006, 35, 814.
[11] J. E. Bulkowski, US patent 4545937, 1984.
[12] M. Réglier, C. Jorand, B. Waegell, J. Chem. Soc., Chem. Com-
mun. 1990, 1752.
(152 mg, 409 μmol) in acetonitrile (10 mL) was added dropwise under
Schlenk conditions to a solution of Lbzm1 (100 mg, 411 μmol) in ace-
tonitrile (10 mL) and stirred for 30 min at room temperature. The solu-
tion was evaporated to yield 154 mg (70%) of a light brown oil.
[13] M. Réglier, E. Amadéi, E. H. Alilou, F. Eydoux, M. Pierrot, B.
Waegell in Bioinorganic Chemistry of Copper (Eds.: K. D.Karlin,
Z. Tyeklár), Chapman & Hall, London, 1993, p. 348.
[14] L. Casella, M. Gullotti, M. Bartosek, G. Pallanza, E. Laurenti, J.
Chem. Soc., Chem. Commun. 1991, 1235.
[15] M. Rolff, J. Schottenheim, G. Peters, F. Tuczek, Angew. Chem.
Int. Ed. 2010, 49, 6483.
[16] For a clear distinction of the different ligands, the ligand L1 [15]
was renamed Lpy1.
[17] M. Réglier, C. Jorand, B. Waegell, J. Chem. Soc., Chem. Com-
mun. 1990, 1752.
C19H27CuF6N5P (M = 533.96 g·mol–1); C 42.24 (calcd. 42.74); H 4.52
(5.10); N 13.76 (13.12)%. H NMR (400 MHz, [D6]acetone, 300 K):
1
δ = 8.07 (s, 1 H, imine H), 7.96 (dd, 2 H, bzm H-6, H-5), 7.37 (m, 2
H, bzm H-4, H-7), 4.26 (t, 2 H, CH2-imine), 3.93 (s, 3 H, CH3-N),
3.62 (t, 2 H, CH2-bzm), 2.29 (s, 6 H, CH3-CN), 1.27 (s, 9 H, CH3).
13C NMR (100 MHz, [D6]acetone, 300 K): δ = 183.25 (CH, imine C),
156.91 (Cq, bzm C-2), 141.83 (Cq, bzm C-3a), 136.46 (Cq, bzm
C-7a),125.73 (Cq, CN), 125.42 (CH, bzm C-6), 125.09 (CH,
bzm C-5), 119.27 (CH, bzm C-4), 112.43 (CH, bzm C-7), 60.92 (CH2,
CH2-imine), 37.84 (Cq, C-(CH3)3), 28.30 (CH3, CH3-N), 27.10 (CH2,
CH2-bzm), 24.53 (CH3, (-CH3)3), 2.68 (CH3-CN).
[18] L. Casella, E. Monzani, M. Gullotti, D. Cavagnino, G. Cerina, L.
Santagostini, R. Ugo, Inorg. Chem. 1996, 35, 7516.
6
© 0000 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Z. Anorg. Allg. Chem. 0000, 0–0